Jaksil, Kadil .

HRN: 14-09-14  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2023
CEFUROXIME 750MG (VIAL)
01/28/2023
02/03/2023
IV
450mg
Q8
AGE
Waiting Final Action 
01/28/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
01/28/2023
02/03/2023
ORAL
3.6ml
TID
AGE
Waiting Final Action 
01/28/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
01/28/2023
01/31/2023
ORAL
5 Ml
12 Hrs
Intestinal Ascariasis
Waiting Final Action 
01/28/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
01/28/2023
02/04/2023
PO
6 Ml
TID
Amoebiasis
Waiting Final Action 
01/28/2023
CEFUROXIME 750MG (VIAL)
01/28/2023
02/04/2023
IV
650 Mg
Q8
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: